The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Adult Hypoglycemic Disorders — Differential Diagnosis & Management

Diagnostic and management approach to spontaneous hypoglycemia in non-diabetic adults including insulinoma, post-bariatric reactive hypoglycemia, factitious hypoglycemia, autoimmune insulin syndrome, and non-islet cell tumor hypoglycemia.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Adult Hypoglycemic Disorders — Differential Diagnosis & Management?

Adult hypoglycemia is documented when Whipple's triad is satisfied: symptoms compatible with hypoglycemia, plasma glucose under 55 mg/dL measured by reliable assay, and resolution of symptoms with glucose correction.

Causes are divided into insulin-mediated (insulinoma, sulfonylurea ingestion, autoimmune insulin syndrome, post-bariatric hypoglycemia) and non-insulin-mediated (non-islet cell tumor with IGF-2, adrenal insufficiency, severe liver disease, drug effects).

Diagnostic workup includes simultaneous insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and sulfonylurea screen drawn during spontaneous or supervised fasting hypoglycemia, with localization studies once biochemical proof of endogenous hyperinsulinism is established.

Symptoms

Adrenergic symptoms — tremor, palpitations, anxiety, sweating, hunger as glucose drops to 55–70 mg/dL
Neuroglycopenic symptoms — confusion, blurred vision, weakness, behavioral change, seizures, coma at glucose under 50 mg/dL
Postprandial symptoms 1–4 hours after meals in reactive or post-bariatric hypoglycemia
Fasting symptoms before breakfast or with prolonged fast suggesting insulinoma
Recurrent unexplained loss of consciousness, automobile accidents, falls in elderly with insulinoma
Weight gain due to defensive eating to prevent hypoglycemic episodes

Risk Factors

Roux-en-Y gastric bypass or sleeve gastrectomy — late post-bariatric hypoglycemia
MEN1 syndrome predisposing to insulinoma
Use of sulfonylureas or insulin secretagogues by patient or family member (factitious or accidental)
Autoimmune disease, Graves disease, Hashimoto thyroiditis (autoimmune insulin antibody syndrome)
Solid tumors (mesenchymal, hepatocellular) producing IGF-2 — non-islet cell tumor hypoglycemia
Adrenal insufficiency, severe liver failure, advanced kidney disease, sepsis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Documented hypoglycemia in non-diabetic adult — endocrinology referral for systematic workup
  • Recurrent unexplained syncope, seizure, or confusion in fasting state — urgent admission for supervised 72-hour fast
  • Postprandial neuroglycopenia after bariatric surgery — bariatric or endocrine specialist
  • Suspicion of factitious hypoglycemia from sulfonylurea exposure — toxicology and safeguarding evaluation
  • Imaging-localized pancreatic mass after biochemical confirmation of insulinoma — surgical referral

Treatment Methods

01
Acute hypoglycemia treated with 15–20 g oral carbohydrate if alert or intravenous dextrose 25–50 g if obtunded; glucagon intramuscularly when no IV access
02
Insulinoma — surgical enucleation or distal pancreatectomy after preoperative localization with EUS, multiphase CT, or 68Ga-exendin-4 PET; minimally invasive approach when feasible
03
Inoperable malignant insulinoma — diazoxide, octreotide or lanreotide, everolimus, sunitinib, or peptide receptor radionuclide therapy
04
Post-bariatric hypoglycemia — small frequent low-glycemic meals, acarbose, GLP-1 receptor antagonist (avexitide), diazoxide, or surgical reversal in refractory cases
05
Treatment of underlying cause for non-islet cell tumor hypoglycemia (tumor resection, glucocorticoids, IGF-1 receptor pathway inhibitors), adrenal insufficiency (hydrocortisone), or autoimmune insulin syndrome (corticosteroids, immunosuppressants)

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.